DELPHOS, Ohio, Oct. 20, 2021 (GLOBE NEWSWIRE) Smilin' Bob's is initiating a voluntary recall because a limited amount of Smilin' Bob's Original Smoked.
Operator
Good day and welcome to the Herc Holdings Inc Fourth Quarter 2020 Earnings Conference Call. [Operator instructions] I would now like to turn the conference over to Elizabeth. Please go ahead.
Elizabeth Higashi
Vice President of Investor Relations
Thank you, Grant. And thank you all for joining us this morning. Welcome, everyone, to our fourth quarter and full year 2020 earnings conference call. Earlier today, our press release, presentation slides and 10-K were filed with the SEC and are all posted on our IR website at ir.hercrentals.com. This morning, I m joined by Larry Silber, President and Chief Executive Officer; Aaron Birnbaum, Senior Vice President and Chief Operating Officer; and Mark Irion, Senior Vice President and Chief Financial Officer. We ll review the fourth quarter and full year, our view of the industry and our strategic outlook.
Share this article
Share this article
METUCHEN, N.J., Jan. 25, 2021 /PRNewswire/ Tevogen Bio today announced it has secured necessary funding from HMP Partners of New Jersey, an investment firm managed by medical doctors, which will allow Tevogen to support all clinical trials of its investigational, potentially curative COVID-19 treatment. Tevogen s Investigational New Drug (IND) application for its proprietary antigen-specific T cell therapy is under review by the U.S. Food and Drug Administration (FDA).
All COVID-19 therapeutics utilized to date have sought to slow the progression of the infection and/or moderate its symptoms. These approaches buy time for the patient s own T cells to activate and respond to the infection, which is the mechanism that the body employs to rid itself of viruses such as the SARS-CoV-2.